Article
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.
European journal of endocrinology - 10 Dec 2021
Cappellani Daniele, Brancatella Alessandro, Morganti Riccardo, Borsari Simona, Baldinotti Fulvia, Caligo Maria Adelaide, Kaufmann Martin, Jones Glenville, Marcocci Claudio, Cetani Filomena
Abstract excerpt
BACKGROUND AND OBJECTIVES: CYP24A1 encodes a 24-hydroxylase involved in vitamin D catabolism, whose loss-of-function results in vitamin D-dependent hypercalcemia. Since the identification of CYP24A1 variants as a cause of idiopathic infantile hypercalcemia, a large body of literature has emerged indicating heterogeneity in penetrance, symptoms, biochemistry, and treatments. The objectives of the present research...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
